Key points are not available for this paper at this time.
receptor and its role in modulating inflammation in vitro, in animal models and in the context of clinical trials were reviewed. Finally, we discuss the clinical potential of the latest cannabinoid-based therapies in inflammatory diseases.
Rakotoarivelo et al. (Thu,) studied this question.